Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Tevogen Bio Inc
< Previous
1
2
3
4
5
Next >
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
July 13, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Announces Formation of a Healthcare Services Initiative
June 09, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
May 28, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
May 21, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Letter to Shareholders from CEO Dr. Ryan Saadi
May 18, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
May 12, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
April 27, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
March 26, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 25, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
March 18, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
March 13, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
March 13, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
March 11, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
March 09, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Letter to Shareholders from CEO Dr. Ryan Saadi
March 06, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
March 05, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Announces Reverse Stock Split
March 04, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
February 27, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
February 26, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
February 26, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
January 30, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue
January 29, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
January 12, 2026
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen CEO Donates Shares to Support Education for Underprivileged Children
December 22, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen CEO Donates Personal Shares to Support Local Fire Department
December 19, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company’s Shares of Common Stock
December 11, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine
December 09, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook
December 08, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q
November 14, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tickers
TVGN
TVGNW
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1